ES2095565T3 - Producto estable en almacen y proceso para aislar rna, dna y proteinas. - Google Patents

Producto estable en almacen y proceso para aislar rna, dna y proteinas.

Info

Publication number
ES2095565T3
ES2095565T3 ES93300522T ES93300522T ES2095565T3 ES 2095565 T3 ES2095565 T3 ES 2095565T3 ES 93300522 T ES93300522 T ES 93300522T ES 93300522 T ES93300522 T ES 93300522T ES 2095565 T3 ES2095565 T3 ES 2095565T3
Authority
ES
Spain
Prior art keywords
dna
proteins
warehouse
stable product
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93300522T
Other languages
English (en)
Inventor
Piotr Chomczynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2095565T3 publication Critical patent/ES2095565T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE DESCRIBEN SOLUCIONES DISOLVENTES AUTOESTABLES Y METODOS PARA EL AISLAMIENTO SIMULTANEO RNA, DNA Y PROTEINAS A PARTIR DE MUESTRAS BIOLOGICAS. LAS SOLUCIONES DISOLVENTES INCLUYEN FENOL Y UN COMPUESTO GUANIDINIO, CON PREFERENCIA EN UNA CONCENTRACION POR DEBAJO APROXIMADAMENTE 2M, QUE ES EFECTIVO EN EL AISLAMIENTO DE FORMA SUSTANCIALMENTE PURA Y RNA SUBDEGRADADA, SUSTANCIALMENTE PURA Y DNA SUBDEGRADADA Y PROTEINAS A PARTIR DE LAS MISMAS MUESTRAS BIOLOGICAS.
ES93300522T 1992-01-28 1993-01-25 Producto estable en almacen y proceso para aislar rna, dna y proteinas. Expired - Lifetime ES2095565T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/826,984 US5346994A (en) 1992-01-28 1992-01-28 Shelf-stable product and process for isolating RNA, DNA and proteins

Publications (1)

Publication Number Publication Date
ES2095565T3 true ES2095565T3 (es) 1997-02-16

Family

ID=25248018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300522T Expired - Lifetime ES2095565T3 (es) 1992-01-28 1993-01-25 Producto estable en almacen y proceso para aislar rna, dna y proteinas.

Country Status (6)

Country Link
US (1) US5346994A (es)
EP (1) EP0554034B1 (es)
JP (1) JP2679929B2 (es)
AT (1) ATE144777T1 (es)
DE (1) DE69305662T2 (es)
ES (1) ES2095565T3 (es)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637687A (en) * 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
JP3784829B2 (ja) * 1994-04-14 2006-06-14 ザ ロックフェラー ユニヴァーシティ 細胞成分を単離する方法、装置及び試薬
US5693784A (en) * 1994-09-19 1997-12-02 Promega Corporation Methods for creating agglomerates from colloidal particles
US5777099A (en) * 1995-02-24 1998-07-07 Biotecx Laboratories, Inc. RNA separation
DE19520398B4 (de) * 1995-06-08 2009-04-16 Roche Diagnostics Gmbh Magnetisches Pigment
KR100463475B1 (ko) 1995-06-08 2005-06-22 로셰 디아그노스틱스 게엠베하 자기성피그먼트
US5945515A (en) * 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
US5804684A (en) * 1995-08-24 1998-09-08 The Theobald Smith Research Institute, Inc. Method for isolating nucleic acids
US5973137A (en) * 1996-02-13 1999-10-26 Gentra Systems, Inc. Low pH RNA isolation reagents, method, and kit
US5777098A (en) * 1996-07-23 1998-07-07 University Of North Dakota Medical Education Research Foundation DNA purification procedure
SE9603599D0 (sv) * 1996-10-02 1996-10-02 Pharmacia Biotech Ab A method of separating a two phase system
US20050287583A1 (en) * 1997-01-21 2005-12-29 Promega Corporation Methods and kits for isolating biological target materials using silica magnetic particles
US6027945A (en) * 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
EP1005479A4 (en) * 1997-04-10 2002-12-18 Life Technologies Inc RNS INSULATION REAGENT AND METHOD
DE19743518A1 (de) * 1997-10-01 1999-04-15 Roche Diagnostics Gmbh Automatisierbare universell anwendbare Probenvorbereitungsmethode
US20050042597A1 (en) * 1997-10-07 2005-02-24 Pham Thuy Diem Viral detection system
JP2001526051A (ja) * 1997-12-10 2001-12-18 シエラ ダイアグノスティクス，インク． 体液中のｄｎａを保存するための方法及び試薬
US7078224B1 (en) 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
US6194562B1 (en) 1998-04-22 2001-02-27 Promega Corporation Endotoxin reduction in nucleic acid purification
US6204375B1 (en) 1998-07-31 2001-03-20 Ambion, Inc. Methods and reagents for preserving RNA in cell and tissue samples
DE19836559A1 (de) 1998-08-12 2000-03-23 Antigen Gmbh Gefäß zur Entnahme von Blut
US6310199B1 (en) 1999-05-14 2001-10-30 Promega Corporation pH dependent ion exchange matrix and method of use in the isolation of nucleic acids
US6270970B1 (en) 1999-05-14 2001-08-07 Promega Corporation Mixed-bed solid phase and its use in the isolation of nucleic acids
WO2001021830A1 (en) * 1999-09-24 2001-03-29 Ambion, Inc. Nuclease inhibitor cocktail
US7264932B2 (en) * 1999-09-24 2007-09-04 Applera Corporation Nuclease inhibitor cocktail
CA2392009C (en) * 1999-11-17 2009-07-14 Roche Diagnostics Gmbh Magnetic glass particles, method for their preparation and uses thereof
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
DE10006662A1 (de) * 2000-02-15 2001-08-23 Antigen Produktions Gmbh Gefäß zur Nukleinsäureanalytik
US6602718B1 (en) 2000-11-08 2003-08-05 Becton, Dickinson And Company Method and device for collecting and stabilizing a biological sample
US6602670B2 (en) * 2000-12-01 2003-08-05 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
NZ546251A (en) * 2000-12-01 2008-01-31 Response Genetics Inc Method of determining epidermal growth factor receptor gene expression in a parafin embedded tiasue sample and correlation of levels thereof with survival rates
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US20020142328A1 (en) * 2000-12-01 2002-10-03 Danenberg Kathleen D. Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
US7049059B2 (en) * 2000-12-01 2006-05-23 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
US7005278B2 (en) * 2001-03-02 2006-02-28 Danenberg Kathleen D Method of determining dihydropyrimidine dehydrogenase gene expression
JP2004523229A (ja) * 2001-01-16 2004-08-05 インヴィトロジェン コーポレーション Ｒｎａ単離のための試薬
US6956111B2 (en) * 2001-03-02 2005-10-18 Response Genetics, Inc. Method of determining dihydropyrimidine dehydrogenase gene expression
WO2002072789A2 (en) * 2001-03-12 2002-09-19 Irm, Llc. Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US6686155B2 (en) * 2001-06-14 2004-02-03 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
US20050032105A1 (en) * 2001-10-12 2005-02-10 Bair Robert Jackson Compositions and methods for using a solid support to purify DNA
US7893228B2 (en) * 2001-10-12 2011-02-22 Qiagen North American Holdings, Inc. Compositions and methods for using a solid support to purify RNA
US7148343B2 (en) * 2001-10-12 2006-12-12 Gentra Systems, Inc. Compositions and methods for using a solid support to purify RNA
IL161357A0 (en) * 2001-10-26 2004-09-27 Immunivest Corp Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
ATE449186T1 (de) 2001-11-28 2009-12-15 Applied Biosystems Llc Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung
US8029803B2 (en) * 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
WO2004076640A2 (en) * 2003-02-25 2004-09-10 Ambion, Inc. Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7267950B2 (en) * 2003-05-01 2007-09-11 Veridex, Lcc Rapid extraction of RNA from cells and tissues
US7488579B2 (en) * 2003-05-06 2009-02-10 Biochain Institute, Inc. Methods and compositions to extract DNA, RNA and protein simultaneously from biological samples
WO2004108925A1 (en) * 2003-06-04 2004-12-16 Qiagen As Method for sequentially isolating dna and rna from the same nucleic acid-containing sample
US8062845B2 (en) * 2003-07-21 2011-11-22 Creighton University Rapid nucleic acid isolation method and compositions
US20050042660A1 (en) * 2003-07-31 2005-02-24 Hall Gerald Edward Devices and methods for isolating RNA
US8007805B2 (en) * 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
AU2004270220B2 (en) 2003-09-05 2009-03-05 The Chinese University Of Hong Kong Method for non-invasive prenatal diagnosis
EP1689884A4 (en) 2003-10-08 2007-04-04 Univ Boston PROCESS FOR THE PRENATAL DIAGNOSIS OF CHROMOSOMAL ABNORMALITIES
US7115719B2 (en) * 2003-12-16 2006-10-03 Gentra Systems, Inc. Formulations and methods for denaturing proteins
US20050164204A1 (en) * 2004-01-27 2005-07-28 Reed Thomas D. Single use lyophilized rnase reagents, and kits and methods for using same
EP1584923A3 (en) * 2004-04-07 2006-01-04 Roche Diagnostics GmbH Stabilization of biomolecules in samples
US7794932B2 (en) * 2004-04-16 2010-09-14 Piotr Chomczynski Reagents and methods for isolation of purified RNA
US7531308B2 (en) * 2004-04-23 2009-05-12 Sigma-Aldrich Co. Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography
US20050277121A1 (en) * 2004-06-11 2005-12-15 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
US20060099605A1 (en) * 2004-11-11 2006-05-11 Hall Gerald E Jr Devices and methods for isolating RNA
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US20060105372A1 (en) 2004-11-05 2006-05-18 Bair Robert J Compositions and methods for purifying nucleic acids from stabilization reagents
WO2006060282A2 (en) 2004-11-30 2006-06-08 Merial Limited Mixing devices for chemical lysis of cells
US7727718B2 (en) * 2005-01-04 2010-06-01 Molecular Research Center, Inc. Reagents for storage and preparation of samples for DNA analysis
CA2594491A1 (en) * 2005-01-21 2006-08-24 The New York Blood Center, Inc. Method for extraction and identification of nucleic acids
US7541144B2 (en) * 2005-01-31 2009-06-02 Agilent Technologies, Inc. RNA labeling method
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
US20060270843A1 (en) * 2005-05-26 2006-11-30 Hall Gerald E Jr Methods for isolation of nucleic acids
US20060269929A1 (en) * 2005-05-26 2006-11-30 Hall Gerald E Jr Methods and kits for DNA purification on polymeric membranes at low ionic strength
WO2007005613A2 (en) * 2005-07-01 2007-01-11 Promega Corporation Network of buoyant particles for biomolecule purification
US7544471B2 (en) 2005-07-30 2009-06-09 Agilent Technologies, Inc. Preparing RNA from a wax-embedded tissue specimen
US20070054168A1 (en) * 2005-09-06 2007-03-08 Hao Chang Zinc/air cell
EP1948802A4 (en) * 2005-10-13 2009-01-14 Virexx Medical Corp CHIMERIC ANTIGEN WITH HEPATITIS C VIRUS POLYPEPTIDE AND FC FRAGMENT FOR CALLING UP AN IMMUNE RESPONSE
WO2007070381A2 (en) 2005-12-09 2007-06-21 Promega Corporation Nucleic acid purification with a binding matrix
WO2007133703A2 (en) * 2006-05-10 2007-11-22 Dxterity Diagnostics Detection of nucleic acid targets using chemically reactive oligonucleotide probes
EP3260556B1 (en) 2006-05-31 2019-07-31 Sequenom, Inc. Methods for the extraction of nucleic acid from a sample
US20070292882A1 (en) * 2006-06-16 2007-12-20 Sysmex Corporation Method and apparatus for detecting cancer cell
JP2008289456A (ja) * 2006-06-16 2008-12-04 Sysmex Corp がん細胞の検出方法及び装置
US20080003585A1 (en) * 2006-06-29 2008-01-03 Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware Purification and amplification of nucleic acids in a microfluidic device
US7687254B2 (en) * 2006-07-11 2010-03-30 Case Western Reserve University Phenol-free method of isolating DNA
CA2660286A1 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
WO2008021431A2 (en) 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2008150187A1 (fr) * 2007-06-08 2008-12-11 Jury Fedorovich Drygin Utilisation du trichloracétate d'ammonium en tant que produit de dissociation de complexes naturels d'acides nucléiques et procédé d'extraction d'arn
WO2009073152A1 (en) * 2007-11-28 2009-06-11 Smart Tube, Inc. Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample
WO2009127350A1 (en) * 2008-04-15 2009-10-22 Universität Bern Method for optimized isolation of rna from fixed tissue
US20110111417A1 (en) 2008-05-14 2011-05-12 Millennium Pharmaceuticals, Inc. Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
DE102008029356A1 (de) 2008-06-20 2009-12-24 Siemens Healthcare Diagnostics Gmbh Verfahren zur Aufreinigung von Nukleinsäuren, insbesondere aus fixiertem Gewebe
DE102008061714A1 (de) 2008-12-12 2010-06-17 Siemens Healthcare Diagnostics Inc., Deerfield Verfahren zur Aufreinigung von Nukleinsäuren, inbesondere aus fixiertem Gewebe
WO2010070657A1 (en) * 2008-12-15 2010-06-24 Council Of Scientific & Industrial Research A composition for the removal of colours and inhibitors from plant tissues to isolate rna
US8846878B1 (en) 2009-01-23 2014-09-30 Cubrc Corporation Method and device for isolating a protein sample
WO2010114599A1 (en) * 2009-04-01 2010-10-07 Dx Terity Diagnostics Inc. Chemical ligation dependent probe amplification (clpa)
US8771948B2 (en) 2009-04-03 2014-07-08 Sequenom, Inc. Nucleic acid preparation compositions and methods
PL2443226T3 (pl) * 2009-06-18 2015-04-30 Merck Patent Gmbh Sposób izolowania komórek
DE202009018981U1 (de) * 2009-07-01 2015-03-11 Axagarius Gmbh & Co. Kg Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit dafür
US8222397B2 (en) * 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
CA2772020A1 (en) * 2009-08-31 2011-03-03 Mbio Diagnostics, Inc. Integrated sample preparation and analyte detection
US10066257B2 (en) 2010-03-29 2018-09-04 Dxterity Diagnostics Incorporated Methods and compositions for detecting target nucleic acids
KR101641113B1 (ko) * 2010-08-18 2016-07-20 도레이 카부시키가이샤 Ｒｎａ 추출용 용액
EP2426201A1 (en) 2010-09-06 2012-03-07 Qiagen GmbH Method of isolating purified RNA with reduced DNA contaminations
US9051563B2 (en) 2011-01-14 2015-06-09 Zymo Research Corporation Nucleic acid purification
JP6096774B2 (ja) 2011-08-12 2017-03-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング 核酸を単離するための方法
WO2013035062A1 (en) 2011-09-06 2013-03-14 North-West University A method of preparing biological material
CA2862580A1 (en) 2011-10-28 2013-05-02 Millennium Pharmaceuticals, Inc. Biomarkers of response to nae inhibitors
CN102505012A (zh) * 2011-12-30 2012-06-20 珠海出入境检验检疫局检验检疫技术中心 一种用于提取动物病毒rna的裂解液
WO2013169861A1 (en) 2012-05-09 2013-11-14 Bio-Rad Laboratories, Inc. Buffer for one-step dna extraction
US9206469B2 (en) 2012-07-18 2015-12-08 Zymo Research Corporation Nucleic acid purification
US10662477B2 (en) 2012-10-01 2020-05-26 Millennium Pharmaceuticals, Inc. Biomarkers and methods to predict response to inhibitors and uses thereof
JP6392857B2 (ja) 2013-05-24 2018-09-19 オッカム バイオラブス，インコーポレイティド 核酸サンプルを回収するためのシステム及び方法
UY36046A (es) 2014-03-26 2015-10-30 Millennium Pharm Inc Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
WO2015191777A2 (en) 2014-06-10 2015-12-17 Dxterity Diagnostics Incorporated Devices and methods for collecting and stabilizing biological samples
JP6767374B2 (ja) 2014-10-20 2020-10-14 ジェン−プローブ・インコーポレーテッド 赤血球溶解溶液
EP3221051A4 (en) 2014-11-21 2018-06-20 Occam Biolabs, Inc. System and method for collecting a sample of nucleic acid
EP3135769A1 (en) 2015-08-26 2017-03-01 Qiagen GmbH Kits and methods for extracting rna
US11427815B2 (en) * 2015-12-28 2022-08-30 Koninklijke Philips N.V. Nucleic acid purification system using a single wash and elution buffer solution
EP3436580B1 (en) 2016-03-30 2021-03-17 Life Technologies AS Improved methods and compositions for nucleic acid isolation
EP3448998B1 (en) 2016-04-27 2020-06-03 Gen-Probe Incorporated Blood cell lysis reagent
EP3555286B1 (en) 2016-12-15 2021-11-10 QIAGEN GmbH Method for isolating highly pure nucleic acid with magnetic particles
EP3609323B1 (en) 2017-03-17 2024-11-13 Syngenta Crop Protection AG Methods and compositions for preserving tissues and nucleic acids
WO2019109016A1 (en) 2017-12-01 2019-06-06 Millennium Pharmaceuticals, Inc. Biomarkers and methods for treatment with nae inhibitors
KR102262992B1 (ko) * 2019-04-15 2021-06-09 대구가톨릭대학교산학협력단 리포폴리사카라이드 추출용 용매 및 이를 이용한 리포폴리사카라이드 추출 방법
CN110951724A (zh) * 2019-12-20 2020-04-03 沈阳农业大学 一种Trizol快速提取核酸DNA和/或RNA的方法
CN112195176B (zh) * 2020-09-30 2023-05-02 天津大潮基因科技有限公司 从生物材料中分离纯化核酸固体的方法
CN117467731A (zh) * 2023-11-07 2024-01-30 合肥贝壳派创新科技有限公司 一种贻贝提取物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843155A (en) * 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5010183A (en) * 1989-07-07 1991-04-23 Macfarlane Donald E Process for purifying DNA and RNA using cationic detergents
US5128247A (en) * 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
ES2125869T3 (es) * 1990-07-13 1999-03-16 Microprobe Corp Composicion no corrosiva y procedimientos utiles para la extraccion de acidos nucleicos.
US5130423A (en) * 1990-07-13 1992-07-14 Microprobe Corporation Non-corrosive compositions and methods useful for the extraction of nucleic acids

Also Published As

Publication number Publication date
EP0554034B1 (en) 1996-10-30
US5346994A (en) 1994-09-13
EP0554034A1 (en) 1993-08-04
ATE144777T1 (de) 1996-11-15
JPH05344886A (ja) 1993-12-27
DE69305662T2 (de) 1997-02-27
DE69305662D1 (de) 1996-12-05
JP2679929B2 (ja) 1997-11-19

Similar Documents

Publication Publication Date Title
ES2073694T3 (es) Metodo para reducir la concentracion de colesterol en alimentos.
ES2097026T3 (es) Procedimiento de fabricacion de cerveza.
AU9058091A (en) Preparation of nucleic acid samples
ATE358177T1 (de) Ein in vitro sortierverfahren
PA8464901A1 (es) Procesos para la sintesis de 1,3-dioles
ES2071706T3 (es) Metodo para fraccionar proteinas plasmaticas.
ATE72121T1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
AR022612A1 (es) Procedimiento para el fraccionamiento de dibutenos y empleo de las fracciones obtenidas con el mismo
ATE144777T1 (de) Brett-stabiles produkt und verfahren zur isolierung der rna, dna und proteine
AU1724097A (en) Lipids and their use, for example, in liposomes
ATE249516T1 (de) Nukleinsäure-isolierung
ES8500996A1 (es) Meotod de producir un polipeptido.
ES2058124T3 (es) Aerosoles que contienen liposomas y metodo para su preparacion.
IT8022740A0 (it) Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati.
NO890715D0 (no) Fremgangsmaate ved preservering av epitelsjikt dyrket in vitro.
DE122011100046I1 (de) In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.
ATE323708T1 (de) Prozess für die produktion von anhydrozucker- alkoholen
ES2144466T3 (es) Metodo de tratamiento de muestras de esputo que contienen mycobacterias.
PT95830A (pt) Processo para o isolamento do factor viii sob a forma de uma fraccao pura directamente de plasma mediante filtracao em gel
Emanuelsson et al. Inhibition of putrescine synthesis blocks development of the polychete Ophryotrocha labronica at gastrulation.
AR023368A1 (es) Proceso microbiano para preparar pravastatina
ES2111651T3 (es) Pesticida y fungicida.
BR8800144A (pt) Processo e aparelho para a producao de alcool
AR000948A1 (es) Proceso para mejorar el efecto de las proantocianidinas y para preparar un producto de proantocianidinas mejorado
ES2096700T3 (es) Procedimiento para la elaboracion de 2-alcoximetilacroleina y su uso para preparar 3-alcoximetilquinolinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 554034

Country of ref document: ES